Akers Biosciences Responds to Erroneous Earnings Call Press Release
Get Alerts AKER Hot Sheet
Join SI Premium – FREE
NEW YORK--(BUSINESS WIRE)-- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER) confirmed that a press release issued earlier today with respect to an earnings call by Aker ASA was issued by a company wholly unrelated to the Company. The press release was errantly issued by the newswire services under the Company’s name. The Company has not scheduled any earnings calls. The Company is investigating how this error occurred and reserves all rights to pursue all appropriate remedies upon learning more about the cause of this error.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210217005868/en/
Investor Relations: Hayden IR
Brett Mass, Managing Partner
Phone: (646) 536-7331
Email: [email protected]
www.haydenir.com
Source: Akers Biosciences, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- California Institution for Women and Gordon Philanthropies Present at the 2024 National Children of Incarcerated Parents Conference
- Defibrillator Market Projected to Surpass US$ 13.98 Bn by 2031 With a Sustained CAGR of 8.71% | Report by SNS Insider
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!